We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

169 hedge funds and large institutions have $282M invested in Spectrum Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

1% more funds holding

Funds holding: 167169 (+2)

2% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 51

8% less call options, than puts

Call options by funds: $5.65M | Put options by funds: $6.12M

60% less capital invested

Capital invested by funds: $708M → $282M (-$426M)

Holders
169
Holders Change
+2
Holders Change %
+1.2%
% of All Funds
3.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
52
Reduced
51
Closed
21
Calls
$5.65M
Puts
$6.12M
Net Calls
-$470K
Net Calls Change
+$9.68M
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
151
Tradewinds Capital Management
Washington
$3K +$5.66K +700 New
MAM
152
Meeder Asset Management
Ohio
$3K +$6.12K +757 +371%
Daiwa Securities Group
153
Daiwa Securities Group
Japan
$2K -$549 -68 -10%
Federated Hermes
154
Federated Hermes
Pennsylvania
$2K -$331 -41 -6%
FHA
155
Flagship Harbor Advisors
Massachusetts
$2K
WCG
156
Weaver Consulting Group
California
$2K
FDCDDQ
157
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.82K
FPFS
158
First Personal Financial Services
North Carolina
$1K
GAM
159
Gemmer Asset Management
California
$1K
TWA
160
TCI Wealth Advisors
Arizona
$1K
Toronto Dominion Bank
161
Toronto Dominion Bank
Ontario, Canada
$1K +$1.21K +150 New
TFO
162
Tarbox Family Office
California
$1K +$1.5K +185 New
SIM
163
Sonora Investment Management
Arizona
-$5.72M -690,234 Closed
SCM
164
Sio Capital Management
New York
-$5M -619,019 Closed
Two Sigma Investments
165
Two Sigma Investments
New York
-$1.39M -167,884 Closed
CAM
166
ClariVest Asset Management
California
-$1.22M -147,282 Closed
KCM
167
Kennedy Capital Management
Missouri
-$1.01M -122,151 Closed
DekaBank Deutsche Girozentrale
168
DekaBank Deutsche Girozentrale
Germany
-$597K -67,400 Closed
QIM
169
Quantitative Investment Management
Virginia
-$357K -43,108 Closed
Voloridge Investment Management
170
Voloridge Investment Management
Florida
-$314K -37,900 Closed
Walleye Capital
171
Walleye Capital
New York
-$213K -26,372 Closed
BAS
172
Brown Advisory Securities
Maryland
-$207K -25,000 Closed
ACM
173
AlphaCrest Capital Management
New York
-$168K -20,300 Closed
QOP
174
Quinn Opportunity Partners
Virginia
-$116K -14,000 Closed
FRM
175
Fox Run Management
Connecticut
-$106K -12,838 Closed

SPPI Hedge Fund Activity: Q4 2019 in Review

169 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2019, worth a combined $282M — down 60% from $708M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SPPI positions and 21 closed out — a net gain of 8 holders — while 52 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $9.99M. The largest seller was Primecap Management, cutting an estimated $36.8M.

  • 169 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2019, up from 167 in Q3 2019.
  • Funds reported $282M of Spectrum Pharmaceuticals Inc stock for Q4 2019, down 60% quarter-over-quarter.
  • 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2019 and 21 closed out, a net change of +8 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2019 was Wellington Management Group, an estimated $9.99M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2019 was Primecap Management, an estimated $36.8M sold.

Based on aggregated 13F filings for Q4 2019.